NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus. (Q48250996)
Jump to navigation
Jump to search
scientific article published on 12 January 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus. |
scientific article published on 12 January 2018 |
Statements
NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus (English)
Hans D Brightbill
Eric Suto
Nicole Blaquiere
Nandhini Ramamoorthi
Swathi Sujatha-Bhaskar
Emily B Gogol
Georgette M Castanedo
Youngsu C Kwon
Susan Haller
Justin Lesch
Karin Bents
Christine Everett
Pawan Bir Kohli
Sandra Linge
Laura Christian
Kathy Barrett
Allan Jaochico
Leonid M Berezhkovskiy
Peter W Fan
Kelli Veliz
Michael J Townsend
Jason DeVoss
Robert Godemann
Wyne P Lee
Cary D Austin
Brent S McKenzie
Steven T Staben
Moulay H Alaoui Ismaili
Lawren C Wu
12 January 2018
1 reference